The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I expansion cohort to evaluate bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumors.
 
Sara Michele Federico
No Relationships to Disclose
 
Mary B McCarville
No Relationships to Disclose
 
Clinton F. Stewart
No Relationships to Disclose
 
Shenghua Mao
No Relationships to Disclose
 
Jianrong Wu
No Relationships to Disclose
 
Andrew M. Davidoff
No Relationships to Disclose
 
Wayne Lee Furman
No Relationships to Disclose
 
Victor M. Santana
No Relationships to Disclose
 
Alberto S. Pappo
Consulting or Advisory Role - ZIOPHARM Oncology
 
Fariba Navid
No Relationships to Disclose